949
Views
6
CrossRef citations to date
0
Altmetric
Author's View

The short and sweet of T-cell therapy

Restraining glycolysis enhances the formation of immunological memory and antitumor immune responses

&
Article: e27573 | Received 13 Dec 2013, Accepted 18 Dec 2013, Published online: 03 Jan 2014

References

  • Gattinoni L, Klebanoff CA, Restifo NP. Paths to stemness: building the ultimate antitumour T cell. Nat Rev Cancer 2012; 12:671 - 84; http://dx.doi.org/10.1038/nrc3322; PMID: 22996603
  • MacIver NJ, Michalek RD, Rathmell JC. Metabolic regulation of T lymphocytes. Annu Rev Immunol 2013; 31:259 - 83; http://dx.doi.org/10.1146/annurev-immunol-032712-095956; PMID: 23298210
  • Pearce EL, Walsh MC, Cejas PJ, Harms GM, Shen H, Wang LS, Jones RG, Choi Y. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 2009; 460:103 - 7; http://dx.doi.org/10.1038/nature08097; PMID: 19494812
  • van der Windt GJ, Everts B, Chang CH, Curtis JD, Freitas TC, Amiel E, Pearce EJ, Pearce EL. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 2012; 36:68 - 78; http://dx.doi.org/10.1016/j.immuni.2011.12.007; PMID: 22206904
  • Chang CH, Curtis JD, Maggi LB Jr., Faubert B, Villarino AV, O’Sullivan D, Huang SC, van der Windt GJ, Blagih J, Qiu J, et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 2013; 153:1239 - 51; http://dx.doi.org/10.1016/j.cell.2013.05.016; PMID: 23746840
  • Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, Chi H. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 2011; 208:1367 - 76; http://dx.doi.org/10.1084/jem.20110278; PMID: 21708926
  • Sukumar M, Liu J, Ji Y, Subramanian M, Crompton JG, Yu Z, Roychoudhuri R, Palmer DC, Muranski P, Karoly ED, et al. Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J Clin Invest 2013; 123:4479 - 88; http://dx.doi.org/10.1172/JCI69589; PMID: 24091329
  • Doedens AL, Phan AT, Stradner MH, Fujimoto JK, Nguyen JV, Yang E, Johnson RS, Goldrath AW. Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen. Nat Immunol 2013; 14:1173 - 82; http://dx.doi.org/10.1038/ni.2714; PMID: 24076634
  • Finlay DK, Rosenzweig E, Sinclair LV, Feijoo-Carnero C, Hukelmann JL, Rolf J, Panteleyev AA, Okkenhaug K, Cantrell DA. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J Exp Med 2012; 209:2441 - 53; http://dx.doi.org/10.1084/jem.20112607; PMID: 23183047
  • Lucas CL, Kuehn HS, Zhao F, Niemela JE, Deenick EK, Palendira U, Avery DT, Moens L, Cannons JL, Biancalana M, et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency. Nat Immunol 2014; 15:88 - 97; http://dx.doi.org/10.1038/ni.2771; PMID: 24165795